I remain optimistic about the product and the company. I have reservations about the investing arm that HLNT brought in. Don't think their pockets are deep enough to bring this product to market. Reasons for that include not finishing the product update on the Hy Impact to "adjust on the fly." Thus, the moving of emphasis on gen sets rather than OTR market. I do have confidence in the present management to work that out. I am amazed how this company has been sued so many times but keeps hanging on and surviving. And I am impressed with their relationship with Lindon Group. I am long and have not sold any shares to date. Just my opinion, for whatever it's worth. My best to all